Sarah R. Williams

Sarah R. Williams

Auto-generated profile, based on publicly available information

Sarah R. Williams

Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine , Baltimore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Eurosurveillance
Verified
Journal Article
Open access
SWSarah R Williams
Sarah R Williams
ADAmanda J Driscoll
Amanda J Driscoll
HLHanna M LeBuhn
Hanna M LeBuhn
WCWilbur H. Chen
Wilbur H. Chen
KNKathleen M Neuzil
Kathleen M Neuzil
JOJustin R. Ortiz
Justin R. Ortiz
Introduction: As SARS-CoV-2 disproportionately affects adults, the COVID-19 pandemic vaccine response will rely on adult immunisation infrastructures. Aim: To assess adult immunisation programmes in World Health Organization (WHO) Member States. Methods: We evaluated country reports from 2018 on adult immunisation programmes sent to WHO and UNICEF. We described existing programmes and used multivariable regression to identify independent factors associated with having them. Results: Of 194 WHO Member States, 120 (62%) reported having at least one adult immunisation programme. The Americas and Europe had the highest proportions of adult immunisation programmes, most commonly for hepatitis B and influenza vaccines (> 47% and > 91% of countries, respectively), while Africa and South-East Asia had the lowest proportions, with < 11% of countries reporting adult immunisation programmes for hepatitis B or influenza vaccines, and none for pneumococcal vaccines. In bivariate analyses, high or upper-middle country income, introduction of new or underused vaccines, having achieved paediatric immunisation coverage goals and meeting National Immunisation Technical Advisory Groups basic functional indicators were significantly associated (p < 0.001) with having an adult immunisation programme. In multivariable analyses, the most strongly associated factor was country income, with high- or upper-middle-income countries significantly more likely to report having an adult immunisation programme (adjusted odds ratio: 19.3; 95% confidence interval: 6.5–57.7). Discussion: Worldwide, 38% of countries lack adult immunisation programmes. COVID-19 vaccine deployment will require national systems for vaccine storage and handling, delivery and waste management to target adult risk groups. There is a need to strengthen immunisation systems to reach adults with COVID-19 vaccines.

1 April 2021 in Vaccine
Verified
Journal Article
Open access
JOJustin R. Ortiz
Justin R. Ortiz
JRJoanie Robertson
Joanie Robertson
JHJui-Shan Hsu
Jui-Shan Hsu
SYStephen Lee Yu
Stephen Lee Yu
ADAmanda J. Driscoll
Amanda J. Driscoll
KNKathleen M. Neuzil
Kathleen M. Neuzil
SARS-CoV-2 vaccines will be deployed to countries with limited immunization systems. We assessed the effect of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in a simulated WHO African Region country using region-specific data on immunization, population, healthcare workers (HCWs), cold storage capacity (quartile values for national and subnational levels), and characteristics of an approved SARS-CoV-2 vaccine. We calculated monthly increases in vaccine doses, doses per vaccinator, and cold storage volumes for four-month SARS-CoV-2 vaccination campaigns targeting risk groups compared to routine immunization baselines. Administering SARS-CoV-2 vaccines to risk groups would increase total monthly doses by 27.0% for ≥ 65 years, 91.7% for chronic diseases patients, and 1.1% for HCWs. Assuming median nurse density estimates adjusted for absenteeism and proportion providing immunization services, SARS-CoV-2 vaccination campaigns would increase total monthly doses per vaccinator by 29.3% for ≥ 65 years, 99.6% for chronic diseases patients, and 1.2% for HCWs. When we applied quartiles of actual African Region country vaccine storage capacity, routine immunization vaccine volumes exceeded national-level storage capacity for at least 75% of countries, but subnational levels had sufficient storage capacity for SARS-CoV-2 vaccines for at least 75% of countries. In the WHO African Region, SARS-CoV-2 vaccination campaigns would substantially increase doses per vaccinator and cold storage capacity requirements over routine immunization baselines. Pandemic vaccination campaigns would increase storage requirements of national-level stores already at their limits, but sufficient capacity exists at subnational levels. Immediate attention to strengthening immunization systems is essential to support pandemic responses.

26 January 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JOJustin R. Ortiz
Justin R. Ortiz
DBDavid Bernstein
David Bernstein
DHDaniel F Hoft
Daniel F Hoft
CWChristopher Wildrick Woods
Christopher Wildrick Woods
MMMicah T McClain
Micah T McClain
KNKathleen M Neuzil
Kathleen M Neuzil
We evaluated the associations between baseline influenza virus–specific hemagglutination inhibition (HAI) and microneutralization (MN) titers and subsequent symptomatic influenza virus infection in a controlled human infection study. We inoculated unvaccinated healthy adults aged 18–49 years with an influenza A/California/04/2009/H1N1pdm-like virus (NCT04044352). We collected serial safety labs, serum for HAI and MN, and nasopharyngeal swabs for reverse-transcription polymerase chain reaction (RT-PCR) testing. Analyses used the putative seroprotective titer of ≥40 for HAI and MN. The primary clinical outcome was mild-to-moderate influenza disease (MMID), defined as ≥1 postchallenge positive qualitative RT-PCR test with a qualifying symptom/clinical finding. Of 76 participants given influenza virus challenge, 54 (71.1%) experienced MMID. Clinical illness was generally very mild. MMID attack rates among participants with baseline titers ≥40 by HAI and MN were 64.9% and 67.9%, respectively, while MMID attack rates among participants with baseline titers <40 by HAI and MN were 76.9% and 78.3%, respectively. The estimated odds of developing MMID decreased by 19% (odds ratio, 0.81 [95% confidence interval, .62–1.06]; P = .126) for every 2-fold increase in baseline HAI. There were no significant adverse events. We achieved a 71.1% attack rate of MMID. High baseline HAI and MN were associated with protection from illness. Clinical Trials Registration. NCT04044352.

4 May 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JOJustin R. Ortiz
Justin R. Ortiz
SYStephen L Yu
Stephen L Yu
ADAmanda J Driscoll
Amanda J Driscoll
SWSarah R Williams
Sarah R Williams
JRJoanie Robertson
Joanie Robertson
KNKathleen M Neuzil
Kathleen M Neuzil
Background: Influenza vaccination is uncommon in low-resource settings. We evaluated aspects of operational feasibility of influenza vaccination programs targeting risk groups in the World Health Organization (WHO) African (AFR) and South-East Asian (SEAR) Regions. Methods: We estimated routine immunization and influenza vaccination campaign doses, doses per vaccinator, and cold storage requirements for 1 simulated country in each region using evidence-based population distribution, vaccination schedule, and vaccine volumes. Influenza vaccination targeted persons <5 years, pregnant women, persons with chronic diseases, persons ≥65 years, and healthcare workers (HCW). For the AFR country, we compared vaccine volumes to actual storage capacities. Results: Targeting HCW had a small operational impact, and subsequent findings exclude this group. During 3-month influenza vaccination campaigns, monthly doses delivered in the AFR country increased from 15.0% for ≥65 years to 93.1% for <5 years and in the SEAR country from 19.6% for pregnant women to 145.0% for persons with chronic diseases. National-level cold storage capacity requirements increased in the AFR country from 4.1% for ≥65 years to 20.3% for <5 years and in the SEAR country from 3.9% for pregnant women to 28.8% for persons with chronic diseases. Subnational-level cold storage capacity requirements increased in the AFR country from 5.9% for ≥65 years to 36.8% for <5 years and the SEAR country from 17.6% for pregnant women to 56.0% for persons with chronic diseases. Conclusions: Influenza vaccination of most risk groups will require substantial increases in doses, doses per vaccinator, and cold storage capacity in countries where infrastructure and resources are limited.

1 May 2021 in Vaccine
Verified
Journal Article
Open access
NSNathan A. Serazin
Nathan A. Serazin
BEBassey Edem
Bassey Edem
SWSarah R. Williams
Sarah R. Williams
JOJustin R. Ortiz
Justin R. Ortiz
AKANAND SHANTARAM KAWADE
ANAND SHANTARAM KAWADE
PBPatricia Bastero
Patricia Bastero
This is a Brighton Collaboration Case Definition of the term “Acute Respiratory Distress Syndrome - ARDS” to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.

10 March 2020 in MedEdPublish
Verified
Journal Article
Open access
PDF file
SWSarah Williams
Sarah Williams
SCShannon Clark
Shannon Clark
SHSharon Humiston
Sharon Humiston
BPBarbara Pahud
Barbara Pahud
DMDonald Middleton
Donald Middleton
KLKadriye Lewis
Kadriye Lewis
This article was migrated. The article was not marked as recommended. Background: Vaccine education during residency is not standardized. Little is known about resident perspectives on vaccines and ideal vaccine training. Methods: A convenience sample of pediatric and family medicine (FM) residents were surveyed using a de novo 22 question survey to understand perspectives on vaccines and current and preferred vaccine education curriculum. Responses were analyzed categorically and compared by resident year using Fisher's Exact test. Results: In October 2016, 126 residents from 9 pediatric and FM programs completed the survey. Resident respondents' training levels varied. Most were 25-29 years old and female. High familiarity with vaccines and agreeing to defer recommended vaccine(s) increased with additional years of training (p<0.01). Most residents want to learn more about vaccine risks, benefits, and communication skills. Preferred training modalities were in-person lectures, online modules, and continuity clinic didactics. Residents rated MMR and Hib vaccines as "highly important" more frequently than they did so for HPV and influenza vaccines. One fifth of respondents reported some degree of hesitancy regarding vaccines. Conclusion: Results provide insight on framework and scope for development of a vaccine education curriculum. Identification of vaccine hesitancy among residents and the rating of certain recommended vaccines as of variable importance underscores the need for resident vaccine training.